Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Knowledge Synthesis Grant

Université Laval

$100,000.00

Health impacts and characteristics of deprescribing interventions in older adults - a systematic review.

EF 2015-16

Résumé
Background In Canada, seniors (aged 65 or older) are the most active consumers of health care: in 2012 over 65% of them had at least five prescription medications. Changes in physiology, a higher prevalence of comorbidity and medication interactions increase the risk of adverse health outcomes related to medication use. This risk is further increased by medication regimens comprising numerous prescriptions. Not all chronic medications may actually benefit seniors. A number of interventions have been tested to optimize or reduce seniors’ medication load, such as complete geriatric evaluation, medication review, educational programs, decision aids, etc. More recently, deprescribing has been defined as a process specifically developed to balance the expected benefits from medications against their risks. Deprescribing interventions lead to discontinuation of chronic medications which are no longer beneficial. Deprescribing trials are being performed and some reviews exist, but evidence on the health effects of deprescribing remains inconclusive. Evidence is also insufficient on which interventions are most successful, limiting the implementation of this approach. Since the concept of deprescribing is gaining interest from clinicians, policy makers and the “Choosing Wisely movement”, this knowledge gap needs to be filled. Objectives We propose a systematic review to answer the following research questions: What are the characteristics of successful deprescribing interventions or elements thereof, which achieve positive or at least neutral outcomes on health or quality of life in seniors? What are the health outcomes of interventions to deprescribe, i.e. reduce the number or dosage of chronic medications, in seniors? Methods Knowledge users (KU) representing geriatricians, family physicians, pharmacists, senior patients, the Ontario OPEN-program, the Quebec Institute for Health Assessement and an Australian medication knowledge broker expressed the need for guidance in discontinuing inappropriate medication, i.e. deprescribing. This systematic review will be imbedded in a knowledge transfer strategy. Our team is experienced in Cochrane reviews, knowledge transfer, health service organization, geriatrics, pharmacology/pharmacy, deprescribing, epidemiology, public health and statistics. The review will be based on the Cochrane method for systematic reviews of interventions and on the PRISMA statement. The protocol is registered in PROSPERO. The search will be conducted for all relevant scientific databases and websites. A sophisticated strategy will be used to identify relevant grey literature. Study selection, data extraction, intervention content and quality assessment will be conducted independently by two reviewers. Meta-analyses will be performed for groups of eligible studies. The KU will participate in the systematic review and develop and implement a dissemination plan for knowledge exchange (KE) and the end of grant KE. A Delphi panel will be convened to determine which successful intervention elements are applicable to the Canadian context. Expected results This review will identify which deprescribing interventions or components thereof are successful and have a positive, or at least a neutral, impact on seniors’ health or quality of life. Results will be instrumental for the development of better interventions, guidelines for clinicians and patients and to improve policies in order to face the challenges of deprescribing among older adults.
Programme
Knowledge Synthesis Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
345979
Name
Kroger Edeltraut
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Health systems / services
Prcname2
Knowledge Synthesis Grant
Projecttitle
Health impacts and characteristics of deprescribing interventions in older adults - a systematic review.
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Knowledge Synthesis Grant
Keyworddelim
Delphi Panel; Deprescribing; Health Outcome; Intervention; Intervention Characteristics; Medication; Meta-Analysis; Systematic Review
Abstract
<html> <body> <p> <strong>Background</strong> </p> <p>In Canada, seniors (aged 65 or older) are the most active consumers of health care: in 2012 over 65%&nbsp;of them had at least five prescription medications. Changes in physiology, a higher prevalence of&nbsp;comorbidity and medication interactions increase the risk of adverse health outcomes related to&nbsp;medication use. This risk is further increased by medication regimens comprising numerous prescriptions.&nbsp;Not all chronic medications may actually benefit seniors. A number of interventions have been tested to optimize or&nbsp;reduce seniors&rsquo; medication load, such as complete geriatric evaluation, medication review, educational&nbsp;programs, decision aids, etc. More recently, deprescribing has been defined&nbsp;as a process specifically developed to balance the expected benefits from medications against their risks.&nbsp;Deprescribing interventions lead to discontinuation of chronic medications which are no longer beneficial.&nbsp;Deprescribing trials are being performed and some reviews exist, but evidence on the health effects of&nbsp;deprescribing remains inconclusive. Evidence is also insufficient on which interventions are most successful,&nbsp;limiting the implementation of this approach. Since the concept of deprescribing is gaining interest from clinicians, policy makers and the &ldquo;Choosing Wisely movement&rdquo;, this knowledge gap needs to be filled.</p> <p> <strong>Objectives</strong> </p> <p>We propose a systematic review to answer the following research questions:</p> <ul> <li>What are the characteristics of successful deprescribing interventions or elements thereof, which achieve positive or at&nbsp;least neutral outcomes on health or quality of life in seniors?</li> </ul> <ul> <li>What are the health outcomes of interventions to deprescribe, i.e. reduce the number or dosage of chronic&nbsp;medications, in seniors?</li> </ul> <p> <strong>Method</strong><strong>s</strong> </p> <p>Knowledge users (KU) representing geriatricians, family physicians, pharmacists, senior patients, the Ontario OPEN-program, the Quebec Institute for Health Assessement and an Australian medication knowledge broker expressed the need for&nbsp;guidance in discontinuing inappropriate medication, i.e. deprescribing. This systematic review will be&nbsp;imbedded in a knowledge transfer strategy. Our team is experienced in Cochrane&nbsp;reviews, knowledge transfer, health service organization, geriatrics,&nbsp;pharmacology/pharmacy,&nbsp;deprescribing, epidemiology, public health and statistics. The review will be based on the Cochrane method&nbsp;for systematic reviews of interventions and on the PRISMA statement. The protocol is registered in&nbsp;PROSPERO. The search will be conducted for all relevant scientific databases and websites. A sophisticated&nbsp;strategy will be used to identify relevant grey literature. Study selection, data extraction, intervention&nbsp;content and quality assessment will be conducted independently by two reviewers. Meta-analyses will be&nbsp;performed for groups of eligible studies. The KU will participate in the systematic review and develop and implement a dissemination plan for knowledge exchange (KE) and the end of grant KE. A Delphi panel will&nbsp;be convened to determine which successful intervention elements are applicable to the Canadian context.</p> <p> <strong>Expected results</strong> </p> <p>This review will identify which deprescribing interventions or components thereof are&nbsp;successful and have a positive, or at least a neutral, impact on seniors&rsquo; health or quality of life. Results will be instrumental for&nbsp;the development of better interventions, guidelines for clinicians and patients and to improve policies in order to face the challenges of deprescribing among older adults.</p> </body> </html>
Competitiondate
201601
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kroger, Edeltraut; Morais, José A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~